These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

821 related articles for article (PubMed ID: 25913364)

  • 1. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections.
    Baelo A; Levato R; Julián E; Crespo A; Astola J; Gavaldà J; Engel E; Mateos-Timoneda MA; Torrents E
    J Control Release; 2015 Jul; 209():150-8. PubMed ID: 25913364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Clearing of Wound-Related Pathogenic Bacterial Biofilms Using Protease-Functionalized Antibiotic Nanocarriers.
    Weldrick PJ; Hardman MJ; Paunov VN
    ACS Appl Mater Interfaces; 2019 Nov; 11(47):43902-43919. PubMed ID: 31718141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of ciprofloxacin complex loaded PLGA nanoparticles for pulmonary treatment of cystic fibrosis infections: Design of experiments approach.
    Günday Türeli N; Türeli AE; Schneider M
    Int J Pharm; 2016 Dec; 515(1-2):343-351. PubMed ID: 27744035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Poly-Lactic-Co-Glycolic Acid Micro- and Nanoparticles of Ciprofloxacin Against Bacterial Biofilms.
    Thomas N; Thorn C; Richter K; Thierry B; Prestidge C
    J Pharm Sci; 2016 Oct; 105(10):3115-3122. PubMed ID: 27519649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved effect of amikacin-loaded poly(D,L-lactide-co-glycolide) nanoparticles against planktonic and biofilm cells of Pseudomonas aeruginosa.
    Sabaeifard P; Abdi-Ali A; Gamazo C; Irache JM; Soudi MR
    J Med Microbiol; 2017 Mar; 66(2):137-148. PubMed ID: 28260589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipenem/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates.
    Shaaban MI; Shaker MA; Mady FM
    J Nanobiotechnology; 2017 Apr; 15(1):29. PubMed ID: 28399890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).
    Deacon J; Abdelghany SM; Quinn DJ; Schmid D; Megaw J; Donnelly RF; Jones DS; Kissenpfennig A; Elborn JS; Gilmore BF; Taggart CC; Scott CJ
    J Control Release; 2015 Jan; 198():55-61. PubMed ID: 25481442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alginate lyase immobilized chitosan nanoparticles of ciprofloxacin for the improved antimicrobial activity against the biofilm associated mucoid P. aeruginosa infection in cystic fibrosis.
    Patel KK; Tripathi M; Pandey N; Agrawal AK; Gade S; Anjum MM; Tilak R; Singh S
    Int J Pharm; 2019 May; 563():30-42. PubMed ID: 30926526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin-loaded PLGA nanoparticles against cystic fibrosis P. aeruginosa lung infections.
    Günday Türeli N; Torge A; Juntke J; Schwarz BC; Schneider-Daum N; Türeli AE; Lehr CM; Schneider M
    Eur J Pharm Biopharm; 2017 Aug; 117():363-371. PubMed ID: 28476373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
    Dillen K; Vandervoort J; Van den Mooter G; Ludwig A
    Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing antibiofilm activity with functional chitosan nanoparticles targeting biofilm cells and biofilm matrix.
    Tan Y; Ma S; Leonhard M; Moser D; Haselmann GM; Wang J; Eder D; Schneider-Stickler B
    Carbohydr Polym; 2018 Nov; 200():35-42. PubMed ID: 30177175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro production of biofilm in a flow cell system in a strain of Pseudomonas aeruginosa and Staphylococcus aureus and determination of efficiency of ciprofloxacin against them.
    Gupta S; Agarwal S; Sahoo DR; Muralidharan S
    Indian J Pathol Microbiol; 2011; 54(3):569-71. PubMed ID: 21934223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial efficacy of inhalable antibiotic-encapsulated biodegradable polymeric nanoparticles against E. coli biofilm cells.
    Cheow WS; Chang MW; Hadinoto K
    J Biomed Nanotechnol; 2010 Aug; 6(4):391-403. PubMed ID: 21323113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasmall TPGS-PLGA Hybrid Nanoparticles for Site-Specific Delivery of Antibiotics into
    Wan F; Bohr SS; Kłodzińska SN; Jumaa H; Huang Z; Nylander T; Thygesen MB; Sørensen KK; Jensen KJ; Sternberg C; Hatzakis N; Mørck Nielsen H
    ACS Appl Mater Interfaces; 2020 Jan; 12(1):380-389. PubMed ID: 31804792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro evaluation of a ciprofloxacin- and ivacaftor-coated sinus stent against Pseudomonas aeruginosa biofilms.
    Cho DY; Lim DJ; Mackey C; Weeks CG; Garcia JAP; Skinner D; Zhang S; McCormick J; Woodworth BA
    Int Forum Allergy Rhinol; 2019 May; 9(5):486-492. PubMed ID: 30702211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amikacin loaded PLGA nanoparticles against Pseudomonas aeruginosa.
    Sabaeifard P; Abdi-Ali A; Soudi MR; Gamazo C; Irache JM
    Eur J Pharm Sci; 2016 Oct; 93():392-8. PubMed ID: 27575877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiofilm Potential of Silver Sulfadiazine-Loaded Nanoparticle Formulations: A Study on the Effect of DNase-I on Microbial Biofilm and Wound Healing Activity.
    Patel KK; Surekha DB; Tripathi M; Anjum MM; Muthu MS; Tilak R; Agrawal AK; Singh S
    Mol Pharm; 2019 Sep; 16(9):3916-3925. PubMed ID: 31318574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization.
    Islan GA; Tornello PC; Abraham GA; Duran N; Castro GR
    Colloids Surf B Biointerfaces; 2016 Jul; 143():168-176. PubMed ID: 27003467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhalable antibiotic delivery using a dry powder co-delivering recombinant deoxyribonuclease and ciprofloxacin for treatment of cystic fibrosis.
    Yang Y; Tsifansky MD; Wu CJ; Yang HI; Schmidt G; Yeo Y
    Pharm Res; 2010 Jan; 27(1):151-60. PubMed ID: 19847626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface charge modulation of rifampicin-loaded PLA nanoparticles to improve antibiotic delivery in Staphylococcus aureus biofilms.
    Da Costa D; Exbrayat-Héritier C; Rambaud B; Megy S; Terreux R; Verrier B; Primard C
    J Nanobiotechnology; 2021 Jan; 19(1):12. PubMed ID: 33413448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.